skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis

(2823) Views  (579) Full article downloads

Authors: Francesco Blasi, Stefano Aliberti, Paolo Tarsia, PierAchille Santus, Stefano Centanni, Luigi Allegra

Published Date May 2007 Volume 2007:2(1) Pages 27 - 31
DOI: http://dx.doi.org/10.2147/COPD.S

Francesco Blasi, Stefano Aliberti, Paolo Tarsia, PierAchille Santus1, Stefano Centanni1, Luigi Allegra

Institute of Respiratory Diseases, University of Milan, Fondazione IRCCS Policlinico-Mangiagalli-Regina Elena Milano, Italy; 1Institute of Lung Disease, Respiratory Unit, San Paolo Hospital, Milan Italy

Abstract: Exacerbations of chronic bronchitis (AECB) are a major cause of morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD), and their impact on public health is increasing. The new fluoroquinolones have an excellent spectrum providing cover for the most important respiratory pathogens, including atypical and “typical” pathogens. Not surprisingly, different guidelines have inserted these agents among the drugs of choice in the empirical therapy of AECB. The pharmacokinetic and dynamic properties of the new fluoroquinolones have a significant impact on their clinical and bacteriological efficacy. They cause a concentration-dependent killing with a sustained post-antibiotic effect. This review discusses the most recent data on the new fluoroquinolone prulifloxacin and critically analyses its activity and safety in the management of AECB.

Keywords: prulifloxacin, exacerbations, chronic bronchitis








Readers of this article also read:

Pulmonary stem cells and the induction of tissue regeneration in the treatment of emphysema
Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
Long-term oxygen therapy: Are we prescribing appropriately?
The influence of the media on COPD patients’ knowledge regarding cardiopulmonary resuscitation
Knowledge and attitudes of family physicians coming to COPD continuing medical education
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
Primary care for diabetes mellitus: perspective from older patients
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio